ANTI-PROLIFERATIVE COMPOUNDS AND THEIR APPLICATIONS Russian patent published in 2024 - IPC C07D413/14 C07D403/04 C07D409/14 C07D413/04 C07D417/14 A61K31/553 A61P35/00 

Abstract RU 2811969 C2

FIELD: pharmaceutics.

SUBSTANCE: compounds of formula I' or their pharmaceutically acceptable salts, pharmaceutical compositions based on them, as well as a method for treating cancer, a method for inducing ER stress, a method for inducing an unfolded protein response (UPR), a method for inducing an unfolded protein response (UPR) and a method for inducing releasing calcium from the endoplasmic reticulum (ER) through a putative Ca2+ channel known as Wolframin (WFS1) using them. In the general formula I', ring A is a ring selected from phenyl, an 8-12 membered partially unsaturated bicyclic heterocyclic ring containing 1-2 heteroatoms independently selected from nitrogen, oxygen or sulfur, a 5-6 membered heteroaromatic ring containing 1 -4 heteroatoms independently selected from nitrogen or sulfur; or an 8-10 membered bicyclic heteroaromatic ring containing 1-5 heteroatoms independently selected from nitrogen; each R1 independently represents hydrogen or straight or branched hydrocarbon chain C1-3, optionally substituted with 1-6 halogens; each of R2 independently represent hydrogen, halogen, -CN, -NO2, -C(O)OR, -C(O)NR2, -NR2, -NRC(O)R, -NRC(O)OR , -NRS(O)2R, -OR, -P(O)R2, -SR, -S(O)R, -S(O)2R, -S(O)(NH)R, -S(O)2NR2 or R; the two R2 groups are optionally taken together to obtain =O; or two R 2 groups are optionally taken together with their intermediate atoms, obtaining a 3-membered saturated spirocyclic ring containing 0 of the heteroatom; each R3 independently represents hydrogen, -OH or a linear or branched hydrocarbon chain C1-3; or the two R3 groups are optionally taken together to give =O; or the two R3 groups are optionally taken together to give =CH2 ; or the two R3 groups are optionally taken together with their intermediate atoms, yielding a 3-8 membered saturated spirocyclic ring containing 0-2 of the heteroatoms independently selected from oxygen; X represents -O- or -CH2-; m is 0, 1 or 2; n is 0, 1, 2, 3, 4 or 5; and p is 0, 1 or 2.

EFFECT: anti-proliferative compounds are proposed.

67 cl, 6 tbl, 60 ex

I’

Similar patents RU2811969C2

Title Year Author Number
PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH 2019
  • Albrecht, Wolfgang
  • Laufer, Stefan
  • Selig, Roland
  • Kloevekorn, Phillip
  • Praefke, Bent
RU2822216C2
BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION 2016
  • Matsuo, Yo
  • Hisada, Shoji
  • Nakamura, Yusuke
  • Chakrabarti, Anjan
  • Rawat, Manish
  • Rai, Sanjay
  • Satyanarayana, Arvapalli, Venkata
  • Duan, Zhiyong
  • Talukdar, Arindam
  • Ravula, Srinivas
  • Decornez, Helene
RU2729187C1
HETEROCYCLIC MAT2A INHIBITORS AND METHODS OF THEIR USE FOR CANCER TREATMENT 2019
  • Konteatis, Zenon, D.
  • Li, Mingzong
  • Reznik, Samuel, K.
  • Sui, Zhihua
RU2809987C2
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES 2018
  • Wang, Bing
  • Chao, Qi
RU2805308C2
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF 2014
  • Ueno Khirokadzu
  • Yamamoto Takasi
  • Miyadzava Tomoko
  • Sinkai Kendzi
  • Arisaka Kharumi
  • Takanokhasi Tosiyuki
RU2667520C9
JAK KINASE-MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF APPLYING THEREOF 2010
  • Abrakham Sanni
  • Chao Tsi
  • Khadd Majkl Dzh.
  • Kholladehj Mark U.
  • Lju Gan
  • Setti Ehduardo
RU2529019C2
COMPOUNDS WHICH ARE ANTAGONISTS OF THE A3-ADENOSINE RECEPTOR, A METHOD FOR PREPARING THEM AND MEDICAL USE THEREOF 2017
  • Lee, Jinhwa
  • Kim, Seungyong
  • Kim, Doran
  • Ahn, Koo Hyeon
  • Lee, Gwi Bin
  • Kim, Dooseop
  • Hwang, Hyun Sook
RU2737157C2
BROMDOMAIN INHIBITORS 2012
  • Wang, Le
  • Pratt, John K.
  • Mcdaniel, Keith F.
  • Dai, Yujia
  • Fidanze, Steven D.
  • Hasvold, Lisa
  • Holms, James H.
  • Kati, Warren M.
  • Liu, Dachun
  • Mantei, Robert A.
  • Mcclellan, William J.
  • Sheppard, George S.
  • Wada, Carol K.
RU2671571C1
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA 2013
  • Achab Abdelgkhani Abe
  • Altman Majkl D.
  • Deng Jongki
  • Kattar Solomon
  • Katts Dzhejson D.
  • Metot Dzhon L.
  • Chzhou Khua
  • Makgovan Meredet
  • Kristofer Mettyu P.
  • Garsiya Yudit
  • Entoni Nevill Dzhon
  • Fradera Linas Fransesk Ksaver
  • Yan Lipin
  • Mu Chanvej
  • Van Syaona
  • Shi Fen
  • E Bajtszyun
  • Chzhan Sisin
  • Chzhao Syaoli
  • Chzhan Zhun
  • Fong Kin Chiu
  • Len Syanshen
RU2661896C2
[1,8]NAPHTHYRIDINE DERIVATIVES, USEFUL AS INHIBITORS OF HCV VIRUS REPLICATION 2006
  • Rokuehj Todd V.
  • Betebenner Dehvid A.
  • Krjuger Allan K.
  • Ivasaki Nobukhiko
  • Kuper Kert S.
  • Anderson Dehvid D.
  • Kempf Dejl Dzh.
  • Mejdigan Dehrold L.
  • Motter Kristofer E.
  • Shehnli Dzhejson P.
  • T'Jufano Majkl D.
  • Vagner Rol'F
  • Chzhan Zhun
  • Molla Akkhteruzzaman
  • Mo Khunmehj
  • Pajlot-Matias Tami
  • Masse Sheri Vl.
  • Kehrrik Robert Dzh.
  • Kheh Vepin
  • Lu Ljantszjun'
RU2467007C2

RU 2 811 969 C2

Authors

Yu, Genri

Klark, Majkl

Bemis, Gaj

Bojd, Majkl

Chandupatla, Kishan

Kollier, Filip

Den, Khunbo

Dun, Khojtszyun

Dorsh, Uorren

Khuver, Rassell,, R.

Dzhonson, Mek, Artur., Ml.

Kulkarni, Shashank

Penni, Marina

Ronkin, Stiven

Takemoto, Darin

Tan, Tsin

Vaal, Natan, D.

Van, Tyanshen

Lauffer, Devid Dzh.

Li, Pan

Dates

2024-01-19Published

2019-04-23Filed